Skip to main content
Skip to main content
DigiCalcs

Practical

Modified Rankin Scale (mRS)

What is Modified Rankin Scale (mRS)?

The Modified Rankin Scale (mRS) is a widely used clinician-reported scale that quantifies the degree of disability and dependence in daily activities following a stroke or other neurological event. Originally developed by John Rankin in 1957 and subsequently modified to its current form, the mRS is the primary functional outcome measure used in virtually all major stroke trials worldwide. It is a simple ordinal scale with seven levels ranging from 0 (no symptoms at all) to 6 (death). Grade 0 represents complete normality; Grade 1 indicates no significant disability despite some symptoms — the patient can carry out all usual duties and activities; Grade 2 represents slight disability where the patient cannot carry out all previous activities but can look after their own affairs without assistance; Grade 3 reflects moderate disability requiring some help but able to walk without assistance; Grade 4 represents moderately severe disability where the patient cannot walk without assistance and cannot attend to their own bodily needs without assistance; Grade 5 indicates severe disability where the patient is bedridden, incontinent, and requires constant nursing care; and Grade 6 is death. The mRS is used to assess outcome at 90 days after stroke onset, which is the standard endpoint in acute stroke trials. A score of 0-2 at 90 days is widely accepted as a favourable functional outcome. The scale's simplicity makes it reproducible across different clinical settings and languages, though its apparent simplicity conceals important inter-rater variability that has led to the development of structured and video-based training programs.

DigiCalcs delivers precision-engineered tools for engineers and STEM professionals.

Formula

f(x)Modified Rankin Scale: 0=No symptoms; 1=No significant disability (all usual duties); 2=Slight disability (looks after own affairs, needs some help); 3=Moderate disability (requires help, walks unaided); 4=Moderately severe (cannot walk or tend to bodily needs without help); 5=Severe disability (bedridden, incontinent, constant care); 6=Dead; No arithmetic — clinical pattern match

Variable Legend

SymbolNameUnitDescription
mRSModified Rankin Scale Grade0-6Ordinal measure of disability from no symptoms (0) to death (6)
FOFavourable OutcomebinarymRS 0-2 at 90 days — the standard primary endpoint in stroke trials

How to Modified Rankin Scale (mRS)

  1. 1Conduct a structured interview with the patient (and carer if appropriate), asking specifically about current ability to perform usual activities and any residual symptoms.
  2. 2Begin at Grade 0 and work upward: confirm whether the patient has any symptoms at all — if none, assign Grade 0.
  3. 3If symptoms are present, assess whether the patient can perform all previous work and social activities — if yes and symptoms are mild, assign Grade 1.
  4. 4If the patient cannot perform all previous activities but can manage all personal care without help, assign Grade 2.
  5. 5If the patient requires some help from others but can still walk without physical assistance, assign Grade 3.
  6. 6If the patient cannot walk unaided or tends to bodily needs without assistance, but does not require round-the-clock care, assign Grade 4.
  7. 7If the patient is bedridden, incontinent, and dependent on others for all care, assign Grade 5; Grade 6 is assigned if the patient has died.

Worked Examples

Example 1Excellent Outcome (mRS 1)
Given:Patient 90 days after mild left hemisphere stroke — reports some word-finding difficulty but returned to work part-time, independent in all self-care
Result:mRS 1 — No significant disability

Considered excellent outcome in stroke trials; classified as favourable outcome

Despite residual aphasia, the patient meets all usual activities criteria and requires no assistance. This is the benchmark for minimal stroke impact.

Example 2Favourable Outcome (mRS 2)
Given:Patient 90 days after moderate right hemisphere stroke — independent in self-care and walking but retired from driving and gave up gardening
Result:mRS 2 — Slight disability

Favourable outcome threshold — important distinction from mRS 3

This patient has given up some previous activities but manages all personal affairs independently. The mRS 0-2 threshold for favourable outcome in trials hinges on this independent function.

Example 3Unfavourable Outcome (mRS 3-4)
Given:Patient 90 days after large MCA stroke — walks with a cane, requires help dressing, cannot manage finances or cooking independently
Result:mRS 3-4 — Moderate to moderately severe disability

Unfavourable outcome; consider rehabilitation goals and carer support

The distinction between mRS 3 (walks unaided) and mRS 4 (cannot walk unaided) is critical and is the most commonly debated boundary in the scale.

Example 4Severe Disability (mRS 5)
Given:Patient 90 days after massive bilateral stroke — bedridden, incontinent, requires feeding and all personal care
Result:mRS 5 — Severe disability

High care needs; nursing home placement often required

Grade 5 represents the highest disability short of death. These patients require round-the-clock care and have very poor quality of life. Palliative care discussions may be appropriate.

Real-World Applications

🏗️

Primary endpoint in all major acute stroke treatment trials including thrombolysis and mechanical thrombectomy studies., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization

🔬

Routine discharge assessment after stroke to document functional level and guide rehabilitation goals and discharge destination., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization

📊

National audit data collection — UK Sentinel Stroke National Audit Programme (SSNAP) records mRS at discharge and 6 months for all stroke admissions., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization

🏥

Informing family members and carers about the patient's likely long-term level of independence after stroke., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization

⚙️

Health economic analyses calculating quality-adjusted life years (QALYs) by mapping mRS levels to utility weights., representing an important application area for the Rankin Scale in professional and analytical contexts where accurate rankin scale calculations directly support informed decision-making, strategic planning, and performance optimization

Special Cases

Pre-existing Disability

In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.

Certain complex rankin scale scenarios may require additional parameters beyond the standard Rankin Scale inputs.

These might include environmental factors, time-dependent variables, regulatory constraints, or domain-specific rankin scale adjustments materially affecting the result. When working on specialized rankin scale applications, consult industry guidelines or domain experts to determine whether supplementary inputs are needed. The standard calculator provides an excellent starting point, but specialized use cases may require extended modeling approaches.

Early vs 90-Day Assessment

In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.

Excellent Neurological Recovery with Social Limitations

In the Rankin Scale, this scenario requires additional caution when interpreting rankin scale results. The standard formula may not fully account for all factors present in this edge case, and supplementary analysis or expert consultation may be warranted. Professional best practice involves documenting assumptions, running sensitivity analyses, and cross-referencing results with alternative methods when rankin scale calculations fall into non-standard territory.

Modified Rankin Scale Grades

GradeDescriptionIndependence LevelTrial Classification
0No symptomsFully independentFavourable
1No significant disabilityAll usual activitiesFavourable
2Slight disabilityIndependent, some activities limitedFavourable
3Moderate disabilityNeeds help, walks unaidedUnfavourable
4Moderately severeNeeds help walking and personal careUnfavourable
5Severe disabilityBedridden, incontinent, constant careUnfavourable
6DeadUnfavourable

Frequently Asked Questions

Q

Why is mRS 0-2 rather than mRS 0-1 used as the favourable outcome threshold?

A

mRS 0-2 was chosen because mRS 2 patients remain independent in personal care and do not require help from others, representing a level of function compatible with independent living even if some previous activities are curtailed. Including mRS 3 would include patients requiring daily assistance, which is generally considered an unfavourable outcome.

Q

What is the inter-rater reliability of the Modified Rankin Scale?

A

The inter-rater reliability of the Modified Rankin Scale (mRS) has been reported to be moderate to high, with studies showing kappa values ranging from 0.55 to 0.83. This indicates that different clinicians can achieve a reasonable level of agreement when using the mRS to assess patients. However, variability in scoring can still occur, particularly at the higher levels of the scale. Clinicians should strive to use standardized training and scoring guidelines to minimize discrepancies.

Q

How does the Modified Rankin Scale compare to other outcome measures, such as the Barthel Index?

A

The Modified Rankin Scale (mRS) and the Barthel Index are both widely used outcome measures in stroke research, but they differ in their focus and scope. The mRS provides a global assessment of disability and dependence, while the Barthel Index is a more detailed measure of activities of daily living (ADLs), with a maximum score of 100. Studies have shown that the mRS and Barthel Index are correlated, but not identical, with a correlation coefficient of around 0.7-0.8. This suggests that both measures capture related but distinct aspects of patient outcome.

Q

Can the Modified Rankin Scale be used in patients with conditions other than stroke?

A

While the Modified Rankin Scale (mRS) was originally developed for use in stroke patients, it has also been applied to other neurological conditions, such as traumatic brain injury, spinal cord injury, and multiple sclerosis. The mRS has been shown to be a reliable and valid measure of disability in these populations, although its responsiveness to change may vary depending on the specific condition. For example, studies have reported that the mRS is more responsive to change in stroke patients than in patients with multiple sclerosis.

Q

What is the minimum clinically important difference (MCID) for the Modified Rankin Scale?

A

The minimum clinically important difference (MCID) for the Modified Rankin Scale (mRS) has been estimated to be around 1 point, although this may vary depending on the patient population and context. For example, a change from mRS 3 to mRS 2 may represent a clinically significant improvement in a patient's level of disability. Studies have also reported that an MCID of 1 point on the mRS corresponds to a change of around 10-15 points on the Barthel Index, highlighting the importance of considering multiple outcome measures when evaluating patient progress.

Common Mistakes to Avoid

  • !Using the neurological examination rather than a structured functional interview to assign mRS — the scale is a functional assessment, not a neurological deficit score.
  • !Confusing mRS 2 and mRS 3 by not explicitly asking whether the patient requires help from another person for any daily activity.
  • !Assigning mRS 3 to a patient who walks with an aid but is otherwise independent — walking aid use alone does not determine grade; it is the need for another person's help that defines grade 3.
  • !Failing to document pre-stroke mRS, making it impossible to determine whether post-stroke disability is new or pre-existing.
  • !Treating mRS as a continuous scale in analyses without accounting for its ordinal nature — appropriate statistical methods (ordinal logistic regression or shift analysis) are required.
  • !Not accounting for the patient's social context — a mRS 2 patient in a supportive household may function very differently from the same score in an isolated patient.
💡

Pro Tip

Use the structured mRS interview format rather than free questioning. Ask explicitly: 'Do you need help from another person to do any of your daily activities?' The answer to this single question most reliably distinguishes mRS 2 from mRS 3, which is the most clinically consequential boundary.

Did you know?

The Rankin Scale was originally published by John Rankin in the Edinburgh Medical Journal in 1957, predating CT scanning by nearly two decades. The scale was modified to its current five-grade form (plus death) in 1988 by van Swieten and colleagues. Despite being over 65 years old, it remains the most widely used outcome measure in stroke medicine worldwide.

📖Difficulty:Beginner
Ask a Question

Have a question about this calculator? Get a detailed answer.

For informational purposes only. This tool is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional.
Mathematically verified
Reviewed July 2026
Our methodology

Get Weekly Math Tips

Join 12,000+ subscribers who get calculator tips every week.

🔒
100% Free
No sign-up ever
Accurate
Verified formulas
Instant
Results as you type
📱
Mobile Ready
All devices

Settings

PrivacyTermsAbout© 2026 DigiCalcs